MK-3475

Will Merck's Anti-PD-1 Therapy be the First to Launch?
Yahoo/Zacks.com
Tue, 07/1/14 - 01:02 pm
Merck
anti-PD-1 immunotherapy
MK-3475
Pharma’s Huge Bet on Immunotherapies
Motley Fool
Wed, 06/25/14 - 07:35 am
immunotherapy
anti-PD-1 immunotherapy
anti-PD-L1
MK-3475
Merck
nivolumab
Roche
Bristol-Myers Squibb
ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy
Yahoo/Benzinga
Thu, 06/5/14 - 12:04 pm
ASCO
cancer immunotherapy
Bristol-Myers Squibb
Yervoy
Merck
MK-3475
ASCO: Bristol-Myers Squibb and Merck Don't Disappoint
Motley Fool
Thu, 06/5/14 - 11:17 am
ASCO
Merck
Bristol-Myers Squibb
anti-PD-1 immunotherapy
MK-3475
Merck Immunotherapy Posts Striking Results Against Advanced Melanoma
TheStreet.com
Mon, 06/2/14 - 10:42 am
Merck
melanoma
ASCO
MK-3475
Immune Therapy’s Cancer Promise Creates Research Rush
Bloomberg
Thu, 05/29/14 - 08:52 am
cancer immunotherapy
Merck
MK-3475
Roche
Yervoy
Bristol-Myers Squibb
Merck KGaA
AstraZeneca
Why Merck Is Still A Big Pharma Kingpin
Seeking Alpha
Mon, 05/5/14 - 08:26 am
Merck
Bristol-Myers Squibb
Gilead Sciences
Roche
MK-3475
hepatitis C
Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Fierce Biotech
Mon, 03/17/14 - 10:53 am
MK-3475
Merck
Five Prime
cancer immunotherapy
Bristol-Myers Squibb
Analysts cheer on Merck's comeback campaign, pumping up blockbuster forecasts
Fierce Biotech
Fri, 02/28/14 - 12:13 pm
Merck
MK-3475
Immune Checkpoint Blocker Race Heats Up
Wall St Cheat Sheet
Tue, 02/18/14 - 10:19 am
immune checkpoint blockers
Yervoy
Bristol-Myers Squibb
MK-3475
Merck
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wed, 02/12/14 - 09:14 am
cancer immunotherapy
Merck
Bristol-Myers Squibb
Amgen
Incyte
Pfizer
MK-3475
Ablynx
Yervoy
Merck & Co., Inc. Pushing The Throttle On Oncology
Motley Fool
Fri, 02/7/14 - 10:29 am
Merck
oncology
cancer
MK-3475
Merck's New Drugs Are Bringing New Hope
Seeking Alpha
Thu, 02/6/14 - 11:59 am
Merck
Januvia
China
India
MK-3475
What to Watch at Amgen, Merck, Pfizer, and Myriad Genetics This Morning
Motley Fool
Wed, 02/5/14 - 10:24 am
Amgen
Merck
Pfizer
Myriad Genetics
Crescendo Biosciences
M&A
MK-3475
Merck Accelerates Cancer-Immunotherapy Program With Three Collaborations
TheStreet.com
Wed, 02/5/14 - 08:42 am
cancer immunotherapy
Merck
Amgen
Incyte
Pfizer
Bristol-Myers Squibb
MK-3475
Merck hits a new high as analyst sees opening for new cancer drug
Marketwatch
Mon, 01/27/14 - 12:00 pm
Merck
MK-3475
lung cancer
Bristol-Myers Squibb
Yervoy
Merck Rises Most Since 2009 on Seeking Early FDA Approval
Bloomberg
Mon, 01/13/14 - 02:41 pm
Merck
FDA
melanoma
MK-3475
Merck and GlaxoSmithKline partner to evaluate renal cell carcinoma regimen
The Fly on the Wall
Wed, 12/18/13 - 09:16 am
renal cell carcinoma
Merck
GSK
MK-3475
pazopanib
Merck Faces Off Against Bristol-Myers' Yervoy
Motley Fool
Mon, 12/2/13 - 05:00 pm
Yervoy
Bristol-Myers Squibb
MK-3475
melanoma
Merck Scores in Investigational Melanoma Study Results
Yahoo/Wall St 24-7
Mon, 11/18/13 - 04:33 pm
Merck
melanoma
MK-3475

Pages